4.7 Article

Inherited IL-18BP deficiency in human fulminant viral hepatitis

期刊

JOURNAL OF EXPERIMENTAL MEDICINE
卷 216, 期 8, 页码 1777-1790

出版社

ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20190669

关键词

-

资金

  1. Investments for the future program (Agence Nationale de la Recherche) [ANR-10-IAHU-01]
  2. Institut National de la Sante et de la Recherche Medicale, Universite Paris Descartes
  3. St. Giles Foundation
  4. Rockefeller University
  5. Howard Hughes Medical Institute
  6. French National Agency for Research on AIDS [18265]
  7. International PhD program of Imagine Institute, Paris, France
  8. National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01-AI091707]
  9. Clinical and Translational Research Fellowship from the American Association for the Study of Liver Diseases Foundation
  10. Jeffrey Modell Foundation
  11. Rockefeller University Center for Basic and Translational Research on Disorders of the Digestive System

向作者/读者索取更多资源

Fulminant viral hepatitis (FVH) is a devastating and unexplained condition that strikes otherwise healthy individuals during primary infection with common liver-tropic viruses. We report a child who died of FVH upon infection with hepatitis A virus (HAV) at age 11 yr and who was homozygous for a private 40-nucleotide deletion in IL18BP, which encodes the IL-18 binding protein (IL-18BP). This mutation is loss-of-function, unlike the variants found in a homozygous state in public databases. We show that human IL-18 and IL-18BP are both secreted mostly by hepatocytes and macrophages in the liver. Moreover, in the absence of IL-18BP, excessive NK cell activation by IL-18 results in uncontrolled killing of human hepatocytes in vitro. Inherited human IL-18BP deficiency thus underlies fulminant HAV hepatitis by unleashing IL-18. These findings provide proof-of-principle that FVH can be caused by single-gene inborn errors that selectively disrupt liver-specific immunity. They also show that human IL-18 is toxic to the liver and that IL-18BP is its antidote.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据